AHK-Cu (100mg)
Specyfikacja techniczna
| Czystość (HPLC) | ≥98% (HPLC) |
| Numer CAS | 72957-37-0 |
| Forma | White lyophilized powder |
| Przechowywanie | -20°C |
| Sekwencja | Ala-His-Lys |
| Masa cząsteczkowa | 340.38 g/mol |
| Forma soli | Acetate |
| Rozpuszczalność | Soluble in water |
AHK-Cu (100mg)
Cena katalogowa w EUR · HU, SK, CZ, PL
- Eurozone (EUR)160,00 EUR
- Węgry (HU)160,00 EUR≈ 64 000 Ft
- Słowacja (SK)160,00 EUR
- Czechy (CZ)160,00 EUR≈ 4 000 Kč
- Polska (PL)160,00 EUR≈ 680,00 zł
Ta sama cena katalogowa w EUR przy dostawie na Węgry, Słowację, Czechy i Polskę. Płatność w EUR.
Orientacyjne kwoty HUF, CZK i PLN przeliczone z EUR; Słowacja stosuje EUR. Kursy przybliżone. Płatność w EUR.
AHK-Cu 100 mg — większy format miedziowego tripeptydu do rozbudowanych protokołów kosmetologicznych/włosowych. Wyłącznie RUO — do badań laboratoryjnych; nie do spożycia przez ludzi.
Wyłącznie do badań laboratoryjnych.
Nie do spożycia przez ludzi, zastosowań weterynaryjnych ani diagnostycznych.
From the Peptide Explorer
A copper-binding tripeptide closely related to GHK-Cu but with stronger selectivity for hair-follicle biology. Widely studied in cosmetic dermatology for promoting VEGF expression in dermal papilla cells, elongating the anagen phase of the hair cycle and improving follicular perfusion.
Key Mechanisms
- ›Copper(II) delivery to dermal tissue
- ›VEGF upregulation in dermal papilla cells
- ›Extension of the anagen (growth) phase
- ›Dermal microvascular angiogenesis
- ›Keratinocyte proliferation
Primary Research Areas
- ›Androgenic alopecia models
- ›Hair follicle cycling
- ›Dermal angiogenesis
- ›Scalp cosmetic research
Key Research Findings
- Induced VEGF expression and elongated anagen phase in dermal papilla cells (Pyo et al., 2007)
- Enhanced follicular cycling in isolated hair follicle organ culture
- Synergistic follicular effects when combined with GHK-Cu and biotinoyl tripeptide-1
Research Overview
A copper-binding tripeptide closely related to GHK-Cu but with stronger selectivity for hair-follicle biology. Widely studied in cosmetic dermatology for promoting VEGF expression in dermal papilla cells, elongating the anagen phase of the hair cycle and improving follicular perfusion.
Origin: Synthetic copper-binding tripeptide analogue of the naturally occurring GHK motif
Mechanism of Action
- Copper(II) delivery to dermal tissue
- VEGF upregulation in dermal papilla cells
- Extension of the anagen (growth) phase
- Dermal microvascular angiogenesis
- Keratinocyte proliferation
Primary Research Areas
- Androgenic alopecia models
- Hair follicle cycling
- Dermal angiogenesis
- Scalp cosmetic research
Key Published Findings
- Induced VEGF expression and elongated anagen phase in dermal papilla cells (Pyo et al., 2007)
- Enhanced follicular cycling in isolated hair follicle organ culture
- Synergistic follicular effects when combined with GHK-Cu and biotinoyl tripeptide-1
Research Protocol
Commonly studied routes: Topical, Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized; protect from light
Important Notice
AHK-Cu (100mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Specyfikacja badawcza
Synthesized for strict analytical consistency. Verified via HPLC/MS.Zobacz standardy jakości →
Przechowywanie i obsługa
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water